Jeffrey W. Albers - 19 Aug 2022 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Role
Director
Signature
/s/ Ariel Hurley, Attorney-in-Fact
Issuer symbol
BPMC
Transactions as of
19 Aug 2022
Net transactions value
-$554,434
Form type
4
Filing time
23 Aug 2022, 17:53:56 UTC
Previous filing
18 Aug 2022
Next filing
07 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Options Exercise $23,866 +1,590 +0.87% $15.01 184,833 19 Aug 2022 Direct F1
transaction BPMC Common Stock Sale $111,332 -1,590 -0.86% $70.02 183,243 19 Aug 2022 Direct F1, F2
transaction BPMC Common Stock Options Exercise $126,234 +8,410 +4.6% $15.01 191,653 22 Aug 2022 Direct F1
transaction BPMC Common Stock Sale $546,002 -7,748 -4% $70.47 183,905 22 Aug 2022 Direct F1, F3
transaction BPMC Common Stock Sale $47,201 -662 -0.36% $71.30 183,243 22 Aug 2022 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 -1,590 -4% $0.000000 38,410 19 Aug 2022 Common Stock 1,590 $15.01 Direct F1, F5
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 -8,410 -22% $0.000000 30,000 22 Aug 2022 Common Stock 8,410 $15.01 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effected pursuant to a trading plan adopted on January 11, 2022 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $70.06 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
F3 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $70.98 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (4)
F4 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $71.03 to $71.49 per share.
F5 This option was granted on February 3, 2016 and is fully vested as of the date hereof.